Questions? +1 (202) 335-3939

Trusted News Since 1995

A service for pharmaceutical industry professionals · Monday, April 28, 2025 · 807,447,472 Articles · 3+ Million Readers

News Search | All News Topics > Pharmaceutical Industry News Topics: By Country | By State

Advanced Options | Search Tips

Search Tips

Here you can find useful examples and description about searching the news archive. Read it carefully to get the best results. If you need more help, please contact us.

Quick Overview

Searching is case insensitive. Words music and mUSIC return the same results.
Some of the common words like the, is, etc. are not included in your search.

Search Term Syntax

The symbol "|" stands for OR and symbol "&" stands for AND.

Term	Description
\|	Using \| operator gives you articles for every keyword in the search term.
&	Using & operator gives you only those articles that contain all keywords in the string.
" " (quotation marks)	Using quotation marks limits your search for exact phrases.
* (asterisk sign)	Using an asterisk sign gives you variations of aroot keyword. You cannot use it in phrases.
(parenthesis)	You can use parenthesis to adjust the priority of your search phrase evaluation (as common math/boolean expressions).

Examples

Keywords (search phrase)	Description
music	will search for any articles that contain the word music
music \| band \| song	will search for articles containing any of the keywords
nhl & hockey	will search for articles containing both words. (Note: & can be omitted in this case)
"white house" \| senate	will search for articles containing the phrase white house or the word senate
"flower show" & tulip	will search for articles containing both the phrase flower show and the word tulip
bank*	will search for articles containing bank, banks, banking, banker etc. Using * (asterisk sign) gives you variations of the root keyword.
student* & ( protest* \| demonstrat* )	will search for articles containing the words student or students, etc. in combinations with protest, protests, demonstrate, demonstration, etc.

Need more help? Contact us at our helpdesk.

Published on 14:24 GMT

Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses OS Endpoint

Pfizer’s investigational anti-PD-1 antibody significantly reduced disease events in patients with high-risk non-muscle-invasive bladder cancer, according to results from a Phase III trial. In a note to investors, Guggenheim analysts noted that these late- …

Source: BioSpace - Pending
Published on 12:25 GMT

Pfizer’s sasanlimab and BCG combination therapy improves EFS in bladder cancer trial

US-based pharmaceutical company Pfizer has reported positive results from a Phase III trial of sasanlimab and Bacillus Calmette-Guérin (BCG) for treating non-muscle invasive bladder cancer (NMIBC). Data from the CREST trial showed that the combination …

Source: Clinical Trials Arena - Pending
Published on 11:22 GMT

Pfizer’s sasanlimab improves event-free survival in phase 3 bladder cancer trial

Pfizer has announced that a phase 3 study evaluating its investigational anti-PD-1 monoclonal antibody sasanlimab in a subset of bladder cancer patients met the primary endpoint of event-free survival. The phase 3 CREST trial has been assessing the …

Source: PMLiVE - Neutral
Published on 16:08 GMT

Merck KGaA springs back into M&A game with $3.9B buyout of Pfizer spinout SpringWorks

Merck KGaA’s long courtship of SpringWorks Therapeutics has come to fruition as the German drugmaker has bought out the Connecticut biopharma for an equity value of $3.9 billion, the companies said on Monday. The deal, which works out to $47 per share, …

Source: Fierce Pharma - Neutral
Published on 16:08 GMT

Regeneron scores EU nod for bispecific antibody Lynozyfic, setting up clash with J&J and Pfizer

After issues at a third-party manufacturer caused the FDA to reject Regeneron's multiple myeloma bispecific antibody linvoseltamab, the company has crossed the regulatory finish line with its new drug in Europe. The European Commission has approved …

Source: Fierce Pharma - Neutral
Published on 01:03 GMT

Nona Biosciences’ Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025

CAMBRIDGE, Mass., April 28, 2025 /PRNewswire/ — Nona Biosciences, a global biotechnology company providing integrated solutions from “Idea to IND” (I to ITM), today announced that its partner, Pfizer, has presented preclinical data on PF-08052666 ( …

Source: The Laotian Times - Indeterminate
Published on Apr 27, 2025

Pfizer Inc. (PFE): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other Billionaire Ken Fisher’s healthcare stock …

Source: Yahoo Finance - Pending
Published on Apr 27, 2025

1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer

• Tariff headlines, ‘Mag 7’ earnings, U.S. jobs report, and PCE inflation data will be in focus this week. • Meta is expected to report better-than-feared earnings due to an improving digital ad market, making it an appealing stock to buy. • Pfizer’s …

Source: Investing - Neutral
Published on Apr 27, 2025

Investing Action Plan: Apple, Amazon, Pfizer, Caterpillar And Sparring With The Fed

Source: Yahoo Finance - Pending
Published on Apr 26, 2025

Can Pfizer's Earnings Spark A Rally?

CHONGQING, CHINA - APRIL 23: In this photo illustration, the logo of Pfizer Inc. is displayed on a ... More smartphone screen, with a stock market chart visible in the background, reflecting trading activity and investor sentiment, on April 23, 2025, in …

Source: Forbes - Neutral